BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee CD, Watanabe Y, Wu NC, Han J, Kumar S, Pholcharee T, Seabright GE, Allen JD, Lin CW, Yang JR, Liu MT, Wu CY, Ward AB, Crispin M, Wilson IA. A cross-neutralizing antibody between HIV-1 and influenza virus. PLoS Pathog 2021;17:e1009407. [PMID: 33750987 DOI: 10.1371/journal.ppat.1009407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Deimel LP, Xue X, Sattentau QJ. Glycans in HIV-1 vaccine design – engaging the shield. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.02.004] [Reference Citation Analysis]
2 Ozdilek A, Avci FY. Glycosylation as a key parameter in the design of nucleic acid vaccines. Current Opinion in Structural Biology 2022;73:102348. [DOI: 10.1016/j.sbi.2022.102348] [Reference Citation Analysis]
3 Miller NL, Clark T, Raman R, Sasisekharan R. Glycans in Virus-Host Interactions: A Structural Perspective. Front Mol Biosci 2021;8:666756. [PMID: 34164431 DOI: 10.3389/fmolb.2021.666756] [Reference Citation Analysis]
4 Stevenson-Leggett P, Armstrong S, Keep S, Britton P, Bickerton E. Analysis of the avian coronavirus spike protein reveals heterogeneity in the glycans present. J Gen Virol 2021;102. [PMID: 34424155 DOI: 10.1099/jgv.0.001642] [Reference Citation Analysis]
5 Deimel LP, Sattentau QJ. Shared sugars – parasite glycan homology in HIV-1 vaccine design. Trends in Parasitology 2022. [DOI: 10.1016/j.pt.2022.04.001] [Reference Citation Analysis]
6 Sette A, Saphire EO. Inducing broad-based immunity against viruses with pandemic potential. Immunity 2022;55:738-48. [PMID: 35545026 DOI: 10.1016/j.immuni.2022.04.010] [Reference Citation Analysis]
7 Wang W, Li Q, Wu J, Hu Y, Wu G, Yu C, Xu K, Liu X, Wang Q, Huang W, Wang L, Wang Y. Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants. Emerg Microbes Infect 2021;10:1519-29. [PMID: 34278967 DOI: 10.1080/22221751.2021.1957720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Huettner I, Krumm SA, Serna S, Brzezicka K, Monaco S, Walpole S, van Diepen A, Allan F, Hicks T, Kimuda S, Emery AM, Landais E, Hokke CH, Angulo J, Reichardt N, Doores KJ; IAVI Protocol C Investigators & The IAVI African HIV Research Network. Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans. Cell Rep 2022;38:110611. [PMID: 35354052 DOI: 10.1016/j.celrep.2022.110611] [Reference Citation Analysis]
9 Williams WB, Meyerhoff RR, Edwards RJ, Li H, Manne K, Nicely NI, Henderson R, Zhou Y, Janowska K, Mansouri K, Gobeil S, Evangelous T, Hora B, Berry M, Abuahmad AY, Sprenz J, Deyton M, Stalls V, Kopp M, Hsu AL, Borgnia MJ, Stewart-Jones GBE, Lee MS, Bronkema N, Moody MA, Wiehe K, Bradley T, Alam SM, Parks RJ, Foulger A, Oguin T, Sempowski GD, Bonsignori M, LaBranche CC, Montefiori DC, Seaman M, Santra S, Perfect J, Francica JR, Lynn GM, Aussedat B, Walkowicz WE, Laga R, Kelsoe G, Saunders KO, Fera D, Kwong PD, Seder RA, Bartesaghi A, Shaw GM, Acharya P, Haynes BF. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies. Cell 2021;184:2955-2972.e25. [PMID: 34019795 DOI: 10.1016/j.cell.2021.04.042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]